Required Reading – Eric Schadt, Nimbus, New York, China, etc.

April 15, 2011

Esquire piece on Pacific Biosciences’ Eric Schadt (link) Bill Gates backs computational drug discovery company, Nimbus (link) New York gets biotech boost (link) Financing and deal making soars in China (link) The cost of drug development is exaggerated (link)

Read the full article →

Complete Genomics – A Look Inside

April 13, 2011

Complete Genomics is a very interesting contender in the rapidly growing industry of DNA sequencing. Rather than selling instruments and reagents like the other companies in this field (Life Technologies, Roche Diagnostics, Illumina, Pacific Biosciences, and others), Complete Genomics has developed their Complete Genomics Analysis (CGA) sequencing-as-a-service platform. The CGA consists of a proprietary sequencing [...]

Read the full article →

Required Reading: Complete Genomics, Business Models, Gates Foundation, etc

April 4, 2011

Complete Genomics releases their first 10-k Annual Report (link to site; link to pdf) Business Model Generation: A great book, about a year old (link) Another industry sponsored technology transfer deal: Gilead & Yale (link) Dendreon wins full reimbursement for prostate cancer treatment Provenge (link) Gates Foundation invests in NanoBiotech Company, Liquidia (link)

Read the full article →

Belated Congrats to Boreal Genomics

April 1, 2011

Boreal Genomics is an exciting new Vancouver upstart that is developing  very interesting genomic technologies.  From their website: “Boreal Genomics presents the Aurora instrument, a new and powerful tool for nucleic acid purification. Aurora incorporates our proprietary SCODA electrophoretic purification technology, which separates and selectively concentrates nucleic acids based on physical, rather than chemical, properties. [...]

Read the full article →

Required Reading: Roche, Stem Cell Therapies, Startups, etc.

November 22, 2010

Roche exists RNAi field (here) ReNeuron enters into first ever clinical trial using neural stem cells (here) Pfizer expands outsourcing of early-stage therapeutic discovery to UCSF (here) Robert Weinberg and Eric Lander found biotech that targets cancer stem cells (here) Web startup financing is in what should be called a bubble but isn’t (here) Silicon [...]

Read the full article →

Launch of Via Science & the Importance of Big Data

November 18, 2010

Colin Hill is the founder of GNS Healthcare, one of the first systems biology informatics companies, and Fina Technologies, a GNS spinout to apply their core informatics to the finance industry.  In a recent move to expand the technology platform underpinning these companies, Hill has launched a parent group Via Science.  As stated on Via Science’s website: [...]

Read the full article →

Oscillations of a Biotech

November 15, 2010

In (somewhat) recent news the FDA halted enrollment of Cardiome Pharma‘s late-stage trial of their atrial fibrillation drug vernakalant.  Reading this article, and then the rest of the news on Cardiome on FierceBiotech, it’s hard not to notice the volatility associated with the company.  As shown in the screenshot, the news seems almost periodic, oscillating between [...]

Read the full article →

Required Reading: Sequencing & Suing, Stem Cells, etc.

November 13, 2010

The 1000 Genomes Project publishes pilot data capturing 95% of human variation (here) All the sequencing companies are suing each other (here) Dr. Mick Bhatia at McMaster University have differentiated human skin cells into blood cells (here) Complete Genomics goes public, but at a lower price (here) Emerging economies are catching the obesity bug (here)

Read the full article →

Bullish on Tools

November 2, 2010

When most folks think of the biotechnology or pharmaceutical industry, they think of companies making pills to treat specific diseases.  Rightfully so.  These companies produce the end products that customers interact with, see the TV commercials for, and hold in their hand.  However, what is not obvious is the massive ecosystem of companies and technologies [...]

Read the full article →

Tesla Opens Former NUMMI Plant

October 29, 2010

For those who read the previous WIRED, you likely enjoyed the recent article on Elon Musk, the CEO of Tesla and Space X. In that article, the author describes NUMMI, the 5.5 million square foot auto manufacturing facility that Tesla recently purchased, to highlight some of the extreme ups and downs Tesla has faced during [...]

Read the full article →

← Previous Entries

Next Entries →